Volumes & Outcomes


Share Gallery

Close Me!
X

Did You Know?


  • Neonatal and pediatric survival rates
  • Top 5 conditions-Neonatal survival
  • Neonatal support mode survival
  • Top 5 conditions- Pediatric survival
  • Pediactic support mode survival
  • Pediatric respiratory survival rates

 

Abbreviations and definitions for terms found in graphs:

CDH=congenital diaphragmatic hernia
MAS=meconium aspiration syndrome
PPHN=persistent pulmonary hypertension
PFC=persistent fetal circulation 
  VV=venovenous
VA=venoarterial
VVDL=double lumen cannula
VVDL+V=double lumen and cephalad jugular cannula 

Congenital diaphragmatic hernia (CHD): a birth defect of the diaphragm

Meconium aspiration syndrome (MAS): a condition that happens in newborns when they breath a mixture of meconium (first feces, or stool) and amniotic fluid into their lungs before or around the time of birth

Persistent pulmonary hypertension (PPHN) or persistent fetal circulation (PFC): a rare, life-threatening condition that happens when a newborn’s circulation system does not adapt to breathing outside of the mother’s womb

Sepsis: a life-threatening infection 

Why do we track this?
We track this data to make sure that we are meeting and improving the standard of care set by the Extracorporeal Life Support Organization (ELSO).

How is Children’s ensuring we are providing high-quality care?

  • We have been recognized as an ECMO Center of Excellence, awarded by the Extracorporeal Life Support Organization (ELSO)—the world’s premier ECMO organization. This award is only for select centers that provide the highest quality of ECMO care, as evidenced by experience with large numbers of children receiving ECMO, extensive training programs, constant review, and use of teamwork to produce excellent outcomes. Children’s has received this recognition every year since the award’s inception in 2007.

     

  • We are members of the ELSO Registry, an international database that allows us to compare ourselves to the world. Our outcomes are consistently among the best in the world, as measured by the Registry data.

 

  • We are a national and international leader in pediatric ECMO with more than 850 cases.

 

  • We are a national leader in the use of the venovenous (VV) approach for ECMO. The VV approach draws blood from a large vein and returns oxygen-rich blood back to the vein. For children without heart failure, this method is very effective and avoids many potential complications of older approaches.

     

  • We use a double lumen catheter (a long thin tube used to give medicine or fluids) whenever possible. This type of catheter can decrease the number of entry points needed, which can help lessen infections that occur with traditional multiple-site catheter placements.

     

  • Children’s is a recognized national leader in developing the innovative techniques, research and training expertise to share with other ECMO programs. One of our team members is a National Institutes of Health (NIH)-funded researcher in developing new ECMO devices.